Oncogenic activation revealed by FGFR2 genetic alterations in intrahepatic cholangiocarcinomas

BACKGROUND: Except for gene fusions, FGFR2 genetic alterations in intrahepatic cholangiocarcinomas (ICCs) have received limited attention, leaving patients harboring activating FGFR2 gene mutations with inadequate access to targeted therapies. EXPERIMENTAL DESIGN: We sought to survey FGFR2 genetic a...

Descripción completa

Detalles Bibliográficos
Autores principales: Pu, Xiaohong, Qi, Liang, Yan, Jia Wu, Ai, Zihe, Wu, Ping, Yang, Fei, Fu, Yao, Li, Xing, Zhang, Min, Sun, Beicheng, Yue, Shen, Chen, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644541/
https://www.ncbi.nlm.nih.gov/pubmed/37964396
http://dx.doi.org/10.1186/s13578-023-01156-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644541/
https://www.ncbi.nlm.nih.gov/pubmed/37964396
http://dx.doi.org/10.1186/s13578-023-01156-7

Ejemplares similares